The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hormonal Contraceptive-Global Market Insights and Sales Trends 2025
Synopsis
Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.
The global Hormonal Contraceptive market size is expected to reach US$ 21910 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Hormonal Contraceptive in various end use industries. The expanding demands from the Hospitals, Household and Clinics,, are propelling Hormonal Contraceptive market. Oral Contraceptive Pills, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Birth Control segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hormonal Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hormonal Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hormonal Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hormonal Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hormonal Contraceptive covered in this report include Ansell Limited, Bayer AG, Church and Dwight Co, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer and Teva Pharmaceutical Industries, etc.
The global Hormonal Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ansell Limited
Bayer AG
Church and Dwight Co
Johnson and Johnson
Mayer Laboratories
Merck and Co
Mylan N.V.
Pfizer
Teva Pharmaceutical Industries
The Female Health Company
Organon International
Afaxys
Global Hormonal Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hormonal Contraceptive market, Segment by Type:
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches
Global Hormonal Contraceptive market, by Application
Hospitals
Household
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hormonal Contraceptive companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.
The global Hormonal Contraceptive market size is expected to reach US$ 21910 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Hormonal Contraceptive in various end use industries. The expanding demands from the Hospitals, Household and Clinics,, are propelling Hormonal Contraceptive market. Oral Contraceptive Pills, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Birth Control segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hormonal Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hormonal Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hormonal Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hormonal Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hormonal Contraceptive covered in this report include Ansell Limited, Bayer AG, Church and Dwight Co, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer and Teva Pharmaceutical Industries, etc.
The global Hormonal Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ansell Limited
Bayer AG
Church and Dwight Co
Johnson and Johnson
Mayer Laboratories
Merck and Co
Mylan N.V.
Pfizer
Teva Pharmaceutical Industries
The Female Health Company
Organon International
Afaxys
Global Hormonal Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hormonal Contraceptive market, Segment by Type:
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches
Global Hormonal Contraceptive market, by Application
Hospitals
Household
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hormonal Contraceptive companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Hormonal Contraceptive
1.1 Hormonal Contraceptive Market Overview
1.1.1 Hormonal Contraceptive Product Scope
1.1.2 Hormonal Contraceptive Market Status and Outlook
1.2 Global Hormonal Contraceptive Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hormonal Contraceptive Market Size by Region (2018-2029)
1.4 Global Hormonal Contraceptive Historic Market Size by Region (2018-2023)
1.5 Global Hormonal Contraceptive Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hormonal Contraceptive Market Size (2018-2029)
1.6.1 North America Hormonal Contraceptive Market Size (2018-2029)
1.6.2 Europe Hormonal Contraceptive Market Size (2018-2029)
1.6.3 Asia-Pacific Hormonal Contraceptive Market Size (2018-2029)
1.6.4 Latin America Hormonal Contraceptive Market Size (2018-2029)
1.6.5 Middle East & Africa Hormonal Contraceptive Market Size (2018-2029)
2 Hormonal Contraceptive Market by Type
2.1 Introduction
2.1.1 Oral Contraceptive Pills
2.1.2 Injectable Birth Control
2.1.3 Emergency Contraceptive Pills
2.1.4 Vaginal Rings
2.1.5 Transdermal Patches
2.2 Global Hormonal Contraceptive Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hormonal Contraceptive Historic Market Size by Type (2018-2023)
2.2.2 Global Hormonal Contraceptive Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hormonal Contraceptive Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hormonal Contraceptive Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hormonal Contraceptive Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hormonal Contraceptive Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hormonal Contraceptive Revenue Breakdown by Type (2018-2029)
3 Hormonal Contraceptive Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Household
3.1.3 Clinics
3.2 Global Hormonal Contraceptive Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hormonal Contraceptive Historic Market Size by Application (2018-2023)
3.2.2 Global Hormonal Contraceptive Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hormonal Contraceptive Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hormonal Contraceptive Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hormonal Contraceptive Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hormonal Contraceptive Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hormonal Contraceptive Revenue Breakdown by Application (2018-2029)
4 Hormonal Contraceptive Competition Analysis by Players
4.1 Global Hormonal Contraceptive Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormonal Contraceptive as of 2022)
4.3 Date of Key Players Enter into Hormonal Contraceptive Market
4.4 Global Top Players Hormonal Contraceptive Headquarters and Area Served
4.5 Key Players Hormonal Contraceptive Product Solution and Service
4.6 Competitive Status
4.6.1 Hormonal Contraceptive Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ansell Limited
5.1.1 Ansell Limited Profile
5.1.2 Ansell Limited Main Business
5.1.3 Ansell Limited Hormonal Contraceptive Products, Services and Solutions
5.1.4 Ansell Limited Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.1.5 Ansell Limited Recent Developments
5.2 Bayer AG
5.2.1 Bayer AG Profile
5.2.2 Bayer AG Main Business
5.2.3 Bayer AG Hormonal Contraceptive Products, Services and Solutions
5.2.4 Bayer AG Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer AG Recent Developments
5.3 Church and Dwight Co
5.3.1 Church and Dwight Co Profile
5.3.2 Church and Dwight Co Main Business
5.3.3 Church and Dwight Co Hormonal Contraceptive Products, Services and Solutions
5.3.4 Church and Dwight Co Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson and Johnson Recent Developments
5.4 Johnson and Johnson
5.4.1 Johnson and Johnson Profile
5.4.2 Johnson and Johnson Main Business
5.4.3 Johnson and Johnson Hormonal Contraceptive Products, Services and Solutions
5.4.4 Johnson and Johnson Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson and Johnson Recent Developments
5.5 Mayer Laboratories
5.5.1 Mayer Laboratories Profile
5.5.2 Mayer Laboratories Main Business
5.5.3 Mayer Laboratories Hormonal Contraceptive Products, Services and Solutions
5.5.4 Mayer Laboratories Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.5.5 Mayer Laboratories Recent Developments
5.6 Merck and Co
5.6.1 Merck and Co Profile
5.6.2 Merck and Co Main Business
5.6.3 Merck and Co Hormonal Contraceptive Products, Services and Solutions
5.6.4 Merck and Co Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.6.5 Merck and Co Recent Developments
5.7 Mylan N.V.
5.7.1 Mylan N.V. Profile
5.7.2 Mylan N.V. Main Business
5.7.3 Mylan N.V. Hormonal Contraceptive Products, Services and Solutions
5.7.4 Mylan N.V. Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.7.5 Mylan N.V. Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Hormonal Contraceptive Products, Services and Solutions
5.8.4 Pfizer Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Hormonal Contraceptive Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
5.10 The Female Health Company
5.10.1 The Female Health Company Profile
5.10.2 The Female Health Company Main Business
5.10.3 The Female Health Company Hormonal Contraceptive Products, Services and Solutions
5.10.4 The Female Health Company Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.10.5 The Female Health Company Recent Developments
5.11 Organon International
5.11.1 Organon International Profile
5.11.2 Organon International Main Business
5.11.3 Organon International Hormonal Contraceptive Products, Services and Solutions
5.11.4 Organon International Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.11.5 Organon International Recent Developments
5.12 Afaxys
5.12.1 Afaxys Profile
5.12.2 Afaxys Main Business
5.12.3 Afaxys Hormonal Contraceptive Products, Services and Solutions
5.12.4 Afaxys Hormonal Contraceptive Revenue (US$ Million) & (2018-2023)
5.12.5 Afaxys Recent Developments
6 North America
6.1 North America Hormonal Contraceptive Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hormonal Contraceptive Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hormonal Contraceptive Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hormonal Contraceptive Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hormonal Contraceptive Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hormonal Contraceptive Market Dynamics
11.1 Hormonal Contraceptive Industry Trends
11.2 Hormonal Contraceptive Market Drivers
11.3 Hormonal Contraceptive Market Challenges
11.4 Hormonal Contraceptive Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
